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Abstract 
 
Background: Moringa oleifera belongs to plant family, Moringaceae and popularly called ―wonderful tree‖, for it is 
used traditionally to cure many diseases including cancer in Africa and Asia, however, there is limited knowledge on 
cytotoxic activity of Moringa oleifera seeds on MCF7 breast cancer cell. The present study evaluated antiproliferative 
effect on MCF7 of the seed. 
Materials and Methods: Seeds of Moringa oleifera were grinded to powder and its phytochemicals were extracted 
using water and 80% ethanol solvents, part of the ethanolic extract were sequentially partitioned to fractions with four 
solvents (hexane, dichloromethane, chloroform, and n-butanol). Antiproliferative effects on MCF7 of the samples were 
determined. Finally, potent samples that significantly inhibited MCF7 growth were tested on MCF 10A.  
Results: Crude water extract, hexane and dichloromethane fractions of the seeds inhibited the proliferation of MCF7 
with the following IC50 values 280 µg/ml, 130 µg/ml and 26 µg/ml respectively, however, of the 3 samples, only 
hexane fraction had minimal cytotoxic effect on MCF 10A (IC50 > 400µg/ml).   
Conclusion: Moringa oleifera seed has antiproliferative effect on MCF7. 
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Abbreviations: CWE-MO, Crude water extracts of Moringa oleifera seeds; CEE-MO, Crude ethanolic extract of 
Moringa oleifera seeds; HF-CEE, Hexane fraction of crude ethanolic extract of Moringa oleifera seeds; DF-CEE, 
Dichloromethane fraction of crude ethanolic extract of Moringa oleifera seeds; CF-CEE, Chloroform fraction of crude 
ethanolic extract of Moringa oleifera seeds; nBF-CEE, n-Butanol fraction of crude ethanolic extract of Moringa 
oleifera seeds; AR-CEE, Aqueous residue of crude ethanolic extract of Moringa oleifera seeds. 
 
 
Introduction 
 
 Herbal medicine has become an alternative remedy to cure, prevent, or manage many diseases such as 
diabetes, cancer, malaria, and microbial infections because it is effective, affordable, easy and simple to prepare. 
Moringa oleifera belongs to the plant family, Moringaceae and popularly called ―wonderful tree‖, for it is used for 
many things such as nutritional and medicinal purposes throughout the world especially in Africa and Asia. It is also 
referred to as horseradish tree or drumstick tree (Verma et al., 2009). Moringa oleifera has significant amount of 
important phytochemicals such as phenolics, flavonoids, alkaloids, vitamins, glycosides, sterols, minerals, and amino 
acids in seeds, leaves, and fruits (Anwar et al., 2007; Sreelatha et al., 2011). Seeds of  Moringa oleifera have been 
found to have diuretic activity (Caceres et al., 1992) as well as antitumor and antimicrobial activities (Guevara et al., 
1999). Costa-Lotufo et al. (2005) reported cytotoxic effect of ethanolic extract of Moringa oleifera root on leukemia 
and melanoma cell lines. However, limited knowledge is available on the cytotoxic activity of Moringa oleifera seeds 
against MCF7. MCF 7 is an estrogen positive breast cancer cell line usually employed as an in vitro model in breast 
cancer therapeutic research(Lee et al., 2015). Breast cancer is a major health concern as it is the most common cancer 
after lung cancer in both genders. In 2012, GLOBOCAN estimated about 1.67 million new breast cancer cases 
throughout the world and ranked it one of the most causes of cancer death in developed and less developed regions of 
the world (Ferlay et al., 2015). Epidemiological studies of breast cancer in Malaysia revealed breast cancer is the 
commonest type of cancer in Malaysian woman (C. H. Yip et al., 2006). Many chemotherapies capable of supressing 
breast cancer growth and preventing metastasis are available, however, associated side effects such as immune system 
compromise, neutropenia, hypercalcemia among others are serious concerns to patients (C. Yip et al., 2014). Hence, 
effective chemotherapy from natural plant source with less adverse effects and minimal toxicity to normal body 
systems is desirable. The present study aims to evaluate cytotoxicity on breast adenocarcinoma cells (MCF7) and 
normal breast cells (MCF10A) of the extracts and fractions from Moringa oleifera seeds. 
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Materials and methods 
Plant collection 
 
 Dried seeds of Moringa oleifera were collected from Herbagus at kepala Batas, Penang, Malaysia in April 
2015. The plant seed was authenticated by a biologist at the School of Biological Science, Universiti Sains Malaysia.  
  
Phytochemical extraction and fractionation 
 
 The dried seeds were manually de-coated and naked seeds were grinded to powder. 10 g of the powdered 
seed was soaked in 100 ml of distilled water and 100 g of the powdered seed was soaked in 400 ml 80% ethanol. 
Mixtures were continuously shaken at 200 rpm for 24 hours. Filtrate was collected by filtration of the mixtures through 
Whatman #1 filter paper. Exhaustive extraction was done by repeating extraction procedure another two times, and 
crude extracts were pooled together. Ethanol was evaporated from pooled ethanolic extract using rotary evaporator and 
the crude water and ethanolic extracts were freeze-dried. For fractionation, 100 g of seed powder was soaked in 80% 
ethanol, phytochemicals were extracted as explained above and alcoholic solvent was evaporated from the extract. 
Extract was then fractioned with solvents of different polarities in a sequential manner based on increasing polarity 
(hexane→ dichloromethane (DCM) → chloroform→ n-butanol) (Figure 1). The fractions were evaporated to remove 
the solvents and lyophilized. All freeze-dried crude and fractionated extracts were kept at 4˚C till further use. 
 
Figure 1: Schematic Diagram showing Extraction and Partitioning of Moringa oleifera seeds 
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Cell culture  
 
 MCF7 and MCF 10A cells were purchased from American Type Culture Collection (ATCC). MCF7 cells 
were cultured and maintained in RPMI 1640 medium supplemented with 10% (v/v) Foetal Bovine Serum (FBS) and 
1% antibiotic, penicillin/streptomycin (PenStrep). MCF 10A cells were grown and maintained in DMEM medium 
supplemented with 5% (v/v) horse serum, 0.2% EGF (20 mg/ml), 0.5 mg/ml hydrocortisone, 10 µg/ml insulin and 1% 
PenStrep. Cells were usually sub-cultured after 4-5 days when it had reached about 80 % confluence. 
 
Cell viability assay 
  
 For this assay, all samples were dissolved in DMSO (0.3% highest final concentration) except crude water 
extract and aqueous residue that were dissolved in media. MCF7 cells were harvested from an exponentially growing 
cell culture that has reached 80% confluence. Cell counting was made and a concentration of 5000 cells/ well (5 × 10
4
 
cells/ml) in 100 µl was seeded to each well of 96 well-plates with exception of few rows for 24 hours in a CO2 saturated 
incubator. The media in the wells were removed and replaced with media containing sample of different concentrations 
(0, 50, 100, 200, 300, and 500µg/ml) dissolved in dimethyl sulfoxide (DMSO) or media. Other wells were filled with 
DMSO (0.3%) containing media or media only as controls. To eliminate absorbance effect of the media and DMSO, an 
empty cell free row in the plate was filled with media containing DMSO or media only. The plates were incubated for 
72 hours. MTS assay was used for cell viability assessment according to manufacturer’s instruction, 20 µl of MTS 
solution was added to each well and plates were incubated in 5% CO2 atmosphere for 3-4 hours. Absorbance values at 
490 nm were taken after incubation using plate reader. Thereafter, anti-proliferation of potent samples (CWE-MO, HF-
CEE, and DF-CEE) on MCF 10A were evaluated using the same methodology described above. Percentage cell 
viability was calculated for different extracts’ concentrations using the following formula;  
Percentage cell viability = {(AE - ADM) ÷ (AC - ADM)} × 100 
            AE = Absorbance of treated cell culture with extract, ADM = Absorbance of media/ media with 0.3% DMSO 
(blank), AC= Absorbance of untreated cell culture (control). 
 
Statistical Analysis  
      
 Numerical values were generated in triplicates for each experiment and data were expressed as mean ± 
standard deviation. Confidence limit of p < 0.05 was considered significant. 
 
Results and Discussion 
Extraction of phytochemical compounds 
 
 Extraction of Moringa oleifera seeds was done using water (aqueous) and 80% ethanol solvents. The crude 
ethanolic extract was further fractioned with different solvents (hexane, dichloromethane, chloroform and n-butanol) 
based on their polarity to various fractions. Water was employed for the extraction because of its universal solubility of 
polar compounds and choice of ethanol was due to its higher solubility, strong extraction ability of plant phytochemicals 
and its tendency of yielding relevant compounds as it has been reported in previous studies on Moringa oleifera 
(Guevara et al., 1999). Part of crude ethanolic extract was fractionated by different solvents to concentrate and enhance 
the purity of active compounds and remove unwanted interferences (Dai & Mumper, 2010) . CWE-MO yield was 25% 
of the dry weight seed powder sample and freeze-dried CEE-MO yielded 11% of the weight of dry seed powder sample 
while the yield of the fractions varied from 0.50 g to 6.66 g according to the following ascending order; AR-CEE (6.66g) 
> n-BF-CEE (2.13 g) > HF-CEE (1.00 g) > DF-CEE (0.50 g) > CF-CEE (nil) (Table 1.). CEE-MO found to be insoluble 
in chloroform may be due to the unsuitability of the solvent or that compounds soluble in chloroform had been 
solubilised by the previous solvents used (hexane and dichloromethane) while the butanol fraction had the highest yield 
amount. 
Table 1: Crude extraction and partitioning yield of Moringa oleifera seeds 
Extract Initial weight of sample (g) Extraction yield (g) % yield 
CEE-MO 100 11.04 11 
CWE-MO 10 2.47 25 
Partitioning of Crude 80% ethanol extract 
Fraction Yield (g) % yield 
HF-CEE 1.00 1 
DF-CEE 0.50 1 
CF-CEE - - 
nBF-CEE 2.13 2 
AR-CEE 6.66 7 
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(-) = nil 
 
Antiproliferative assay on MCF7 and MCF 10A 
 
 The crude extracts and fractions of Moringa oleifera seeds were tested on MCF7 breast cancer cell to 
determine their inhibitory effects on the cell proliferation (Fig. 4). As reported by Al-Asmari et al. (2015), CEE-MO 
had insignificant antiproliferative effect on the cells, however, upon partitioning, HF-CEE and DF-CEE had inhibitory 
effects on the cell proliferation in a dose dependent manner. CWE-MO also inhibited MCF7 proliferation. The half 
inhibitory concentration (IC50) of CWE-MO, HF-CEE, and DF-CEE were 280 µg/ml, 130 µg/ml and 26 µg/ml 
respectively. Hence, DF-CEE was most effective and had relatively highest cytotoxicity on the cells with least IC50.  
 Inhibition of breast cancer cell (MCF7) growth by CWE-MO, HF-CEE and DF-CEE may be due to the 
antioxidant activities of the phenolics the samples contain. Our observations are consistent with several past works that 
have linked the antioxidant activities of phenolic compounds to their antiproliferative effects on various cancer cells 
(Diogo et al., 2009; Goel et al., 2008; Sa et al., 2010; Saeidnia & Abdollahi, 2013). Moreover, antiproliferative effects 
of the analysed samples may also be attributed to the non-phenolic compound, hexadecanoic acid (palmitic acid) in the 
samples as identified by GC-MS analyses, since it had been shown to have selective in vitro cytotoxicity against 
leukemic cells and in vivo antitumor in mice (Al-Asmari et al., 2015; Harada et al., 2001). 
 The samples (CWE-MO, HF-CEE and DF-CEE) that showed anticancer activity on MCF7 were tested on 
non-tumour breast cell (MCF 10A) and their antiproliferative effects on MCF7 and MCF 10A are shown in Fig. 3. 
IC50 values of the CWE-MO, HF-CEE and DF-CEE were 70 µg/ml, >400 µg/ml, and 25 µg/ml respectively. The HF-
CEE was found to have least inhibitory effect on MCF 10A with higher IC50 when compared with its effect on MCF7 
cancer cell. CWE-MO was found to have higher antiproliferative effect on normal cell MCF 10A compared to MCF7 
while DF-CEE inhibited both MCF 10A and MCF7 proliferation at almost the same rate with approximately equal IC50 
values. The HF-CEE was found to be most adequate as it contains potent anticancer agent against MCF7 cell with 
limited cytotoxicity to normal breast cell. 
 
 
 
Figure 2: Antiproliferative effects of Moringa oleifera seeds on MCF7. Inhibitory effects of the samples on MCF7 cell 
proliferation were determined by MTS assay. Crude water extract, hexane and dichloromethane fractions significantly 
suppress MCF7 proliferation. 
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Figure 3: Antiproliferative effects of Moringa oleifera seeds on MCF 10A 
 
Conclusion 
 
 In this study, we extracted phytochemicals from Moringa oleifera seeds, fractionated ethanolic extract 
and cytotoxicity of the extracts and fractions on MCF7 and MCF 10A were determined, our result showed that HF-
CEE (IC50 = 130µg/ml) has antiproliferative effect on MCF7 breast cancer cell with insignificant cytotoxicity to MCF 
10A normal breast cell, however, molecular analyses of action mechanism of the fraction along cancer signalling 
pathways are required.  
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